Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers.
about
Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Favorable immune signature in ...... t prevent second skin cancers.
@en
Favorable immune signature in ...... t prevent second skin cancers.
@nl
type
label
Favorable immune signature in ...... t prevent second skin cancers.
@en
Favorable immune signature in ...... t prevent second skin cancers.
@nl
prefLabel
Favorable immune signature in ...... t prevent second skin cancers.
@en
Favorable immune signature in ...... t prevent second skin cancers.
@nl
P2093
P2860
P1433
P1476
Favorable immune signature in ...... t prevent second skin cancers.
@en
P2093
Annika Nelde
Benjamin Weide
Daniel Johannes Kowalewski
Helmut Rainer Salih
Juliane Sarah Walz
Linus Backert
Lothar Kanz
Oliver Kohlbacher
P2860
P356
10.1080/10428194.2017.1403022
P577
2018-01-03T00:00:00Z